SillaJen, Inc. (215600.KQ)

KRW 2565.0

(0.79%)

Inventory Summary of SillaJen, Inc.

SillaJen, Inc.'s latest annual inventory in 2023 was 1.21 Billion KRW , up 55.56% from previous year.
SillaJen, Inc.'s latest quarterly inventory in 2024 Q2 was 1.34 Billion KRW , down -6.92% from previous quarter.
SillaJen, Inc. reported annual inventory of 779.54 Million KRW in 2022, up 101.32% from previous year.
SillaJen, Inc. reported annual inventory of -59.19 Billion KRW in 2021, down -626.25% from previous year.
SillaJen, Inc. reported quarterly inventory of 1.44 Billion KRW for 2024 Q1, up 18.78% from previous quarter.
SillaJen, Inc. reported quarterly inventory of 1.21 Billion KRW for 2023 FY, up 55.56% from previous quarter.

Annual Inventory Chart of SillaJen, Inc. (2023 - 2014)

Historical Annual Inventory of SillaJen, Inc. (2023 - 2014)

Year	Inventory	Inventory Growth
2023	1.21 Billion KRW	55.56%
2022	779.54 Million KRW	101.32%
2021	-59.19 Billion KRW	-626.25%
2020	-8.15 Billion KRW	70.98%
2019	-28.08 Billion KRW	64.11%
2018	-78.26 Billion KRW	0.38%
2017	-78.56 Billion KRW	48.6%
2016	-152.85 Billion KRW	-15285385332100.0%
2015	1.00 KRW	0.0%
2014	- KRW	0.0%

Year	Inventory	Inventory Growth
2024 Q2	1.34 Billion KRW	-6.92%
2024 Q1	1.44 Billion KRW	18.78%
2023 FY	1.21 Billion KRW	55.56%
2023 Q3	1 Billion KRW	-40.84%
2023 Q1	847.69 Million KRW	8.74%
2023 Q4	1.21 Billion KRW	20.2%
2023 Q2	1.7 Billion KRW	101.15%
2022 Q2	596.1 Million KRW	35.84%
2022 Q4	779.54 Million KRW	-27.25%
2022 FY	779.54 Million KRW	101.32%
2022 Q3	1.07 Billion KRW	79.76%
2022 Q1	438.83 Million KRW	100.74%
2021 FY	-59.19 Billion KRW	-626.25%
2021 Q2	-8.16 Billion KRW	-0.15%
2021 Q3	-20.1 Billion KRW	-146.13%
2021 Q4	-59.19 Billion KRW	-194.47%
2021 Q1	-8.15 Billion KRW	-0.05%
2020 Q4	-8.15 Billion KRW	19.66%
2020 FY	-8.15 Billion KRW	70.98%
2020 Q3	-10.14 Billion KRW	49.63%
2020 Q2	-20.14 Billion KRW	0.08%
2020 Q1	-20.15 Billion KRW	28.23%
2019 FY	-28.08 Billion KRW	64.11%
2019 Q4	-28.08 Billion KRW	76.08%
2019 Q3	-117.41 Billion KRW	-26.51%
2019 Q2	-92.81 Billion KRW	-7.36%
2019 Q1	-86.44 Billion KRW	-10.45%
2018 Q4	-78.26 Billion KRW	-56.42%
2018 Q2	-81.11 Billion KRW	3.16%
2018 Q3	-50.03 Billion KRW	38.31%
2018 Q1	-83.76 Billion KRW	-6.61%
2018 FY	-78.26 Billion KRW	0.38%
2017 Q2	-94.46 Billion KRW	29.4%
2017 Q1	-133.8 Billion KRW	12.46%
2017 Q4	-78.56 Billion KRW	-20.2%
2017 Q3	-65.36 Billion KRW	30.8%
2017 FY	-78.56 Billion KRW	48.6%
2016 Q2	-50.25 Billion KRW	0.0%
2016 Q4	-152.85 Billion KRW	-303.44%
2016 Q3	-37.88 Billion KRW	24.61%
2016 Q1	- KRW	-100.0%
2016 FY	-152.85 Billion KRW	-15285385332100.0%
2015 Q1	1.00 KRW	0.0%
2015 Q3	- KRW	0.0%
2015 Q4	1.00 KRW	0.0%
2015 Q2	- KRW	-100.0%
2015 FY	1.00 KRW	0.0%
2014 FY	- KRW	0.0%
2014 Q4	- KRW	0.0%

Peer Inventory Comparison of SillaJen, Inc.

Name	Inventory	Inventory Difference
HLB Co., Ltd.	11.42 Billion KRW	89.383%
iNtRON Biotechnology, Inc.	1.01 Billion KRW	-19.931%
BINEX Co., Ltd.	28.26 Billion KRW	95.709%
Bioneer Corporation	41.35 Billion KRW	97.068%
Anterogen.Co.,Ltd.	1.91 Billion KRW	36.529%
MEDIPOST Co., Ltd.	14.51 Billion KRW	91.647%
CrystalGenomics, Inc.	1.55 Billion USD	22.007%
Helixmith Co., Ltd	914.11 Million KRW	-32.656%
Chabiotech Co.,Ltd.	34.11 Billion KRW	96.446%
Medy-Tox Inc.	59.61 Billion KRW	97.966%
Peptron, Inc.	172.18 Million KRW	-604.247%
Amicogen, Inc.	46.83 Billion KRW	97.411%
Genexine, Inc.	3.8 Billion KRW	68.147%
HLB Therapeutics Co.,Ltd.	5.33 Billion KRW	77.274%
LegoChem Biosciences, Inc.	196.83 Million KRW	-516.063%
ALTEOGEN Inc.	1.06 Billion KRW	-13.503%
PharmaResearch Co., Ltd.	50.23 Billion KRW	97.586%
JETEMA, Co., Ltd.	12.74 Billion KRW	90.482%
OliX Pharmaceuticals,Inc	468.4 Million KRW	-158.881%
Genomictree Inc.	496.53 Million KRW	-144.219%
MedPacto, Inc.	620.00 KRW	-195584527.903%
D&D Pharmatech	3.45 Billion KRW	64.854%
EASY BIO,Inc.	25.93 Billion KRW	95.325%
GI Innovation, Inc.	- KRW	-Infinity%